In addition to the differences between ours and the O’Bryant study (e.g., healthy cohort vs. AD case/control cohort and expression analysis vs. genetic association analysis), we do not know how the majority of SNPs in our study might affect BDNF levels or function in brain regions or in serum to allow comparison of results. This evidence concerns the gene BDNF and Alzheimer disease.